Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clifton E Barry

Showing results (61-70 of 264) with videos related to

Pageof 27
Sort By:
Mucosal Immunology|August 20, 2020
MAIT cell-directed therapy of Mycobacterium tuberculosis infectionShunsuke Sakai, Keith D Kauffman, Sangmi Oh, et al.
Protein Science : a Publication of the Protein Society|February 4, 2015
Molecular insights into the binding of coenzyme F420 to the conserved protein Rv1155 from Mycobacterium tuberculosisEllene H Mashalidis, Apostolos G Gittis, Aurelie Tomczak, et al.
Bioorganic & Medicinal Chemistry|October 1, 2013
Structure-activity relationships of 2-aminothiazoles effective against Mycobacterium tuberculosisAnja Meissner, Helena I Boshoff, Mahalakshmi Vasan, et al.
Journal of Microbiological Methods|June 1, 2014
Detection of stealthy small amphiphilic biomarkersRama Murthy Sakamuri, Petr Capek, Tobin J Dickerson, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2006
Mycobacterium leprae is naturally resistant to PA-824Ujjini H Manjunatha, Ramanuj Lahiri, Baljit Randhawa, et al.
ACS Infectious Diseases|January 25, 2018
Role of Chemical Biology in Tuberculosis Drug Discovery and DiagnosisKatharina Kolbe, Sri Kumar Veleti, Emma E Johnson, et al.
The Journal of Biological Chemistry|November 26, 2008
Proteasomal protein degradation in Mycobacteria is dependent upon a prokaryotic ubiquitin-like proteinKristin E Burns, Wei-Ting Liu, Helena I M Boshoff, et al.
Nature Medicine|June 13, 2025
Strategies for shortening tuberculosis therapyVéronique A Dartois, Valerie Mizrahi, Radojka M Savic, et al.
Organic Letters|October 6, 2006
Design, synthesis, and biological evaluation of beta-ketosulfonamide adenylation inhibitors as potential antitubercular agentsJagadeshwar Vannada, Eric M Bennett, Daniel J Wilson, et al.
Plos One|November 24, 2011
Rv2607 from Mycobacterium tuberculosis is a pyridoxine 5'-phosphate oxidase with unusual substrate specificityEllene H Mashalidis, Tathagata Mukherjee, Paweł Sledź, et al.
Pageof 27

Showing results (61-70 of 264) with videos related to

Sort By:
Pageof 27
Mucosal Immunology|August 20, 2020
MAIT cell-directed therapy of Mycobacterium tuberculosis infectionShunsuke Sakai, Keith D Kauffman, Sangmi Oh, et al.
Protein Science : a Publication of the Protein Society|February 4, 2015
Molecular insights into the binding of coenzyme F420 to the conserved protein Rv1155 from Mycobacterium tuberculosisEllene H Mashalidis, Apostolos G Gittis, Aurelie Tomczak, et al.
Bioorganic & Medicinal Chemistry|October 1, 2013
Structure-activity relationships of 2-aminothiazoles effective against Mycobacterium tuberculosisAnja Meissner, Helena I Boshoff, Mahalakshmi Vasan, et al.
Journal of Microbiological Methods|June 1, 2014
Detection of stealthy small amphiphilic biomarkersRama Murthy Sakamuri, Petr Capek, Tobin J Dickerson, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2006
Mycobacterium leprae is naturally resistant to PA-824Ujjini H Manjunatha, Ramanuj Lahiri, Baljit Randhawa, et al.
ACS Infectious Diseases|January 25, 2018
Role of Chemical Biology in Tuberculosis Drug Discovery and DiagnosisKatharina Kolbe, Sri Kumar Veleti, Emma E Johnson, et al.
The Journal of Biological Chemistry|November 26, 2008
Proteasomal protein degradation in Mycobacteria is dependent upon a prokaryotic ubiquitin-like proteinKristin E Burns, Wei-Ting Liu, Helena I M Boshoff, et al.
Nature Medicine|June 13, 2025
Strategies for shortening tuberculosis therapyVéronique A Dartois, Valerie Mizrahi, Radojka M Savic, et al.
Organic Letters|October 6, 2006
Design, synthesis, and biological evaluation of beta-ketosulfonamide adenylation inhibitors as potential antitubercular agentsJagadeshwar Vannada, Eric M Bennett, Daniel J Wilson, et al.
Plos One|November 24, 2011
Rv2607 from Mycobacterium tuberculosis is a pyridoxine 5'-phosphate oxidase with unusual substrate specificityEllene H Mashalidis, Tathagata Mukherjee, Paweł Sledź, et al.
Pageof 27